Global reach Graftys marketing and distribution cover over 25 countries, including Europe and the USA, indicating existing international channels and potential for expanding sales partnerships or white-label arrangements with orthopedic distributors in additional markets.

Strategic partnerships Past collaboration with OrthoPediatrics and acquisition activity signal openness to co-development, private-label opportunities, and strategic alliances that can broaden product adoption in pediatric and general orthopedic segments.

Regenerative focus Specialized, resorbable calcium-phosphate bone cements for reconstructive orthopedic surgery positions Graftys in a niche high-value biomaterials space with potential upsell to hospitals and clinics seeking advanced bone regeneration solutions.

Financial runway Current revenue under $1M with $13M in funding suggests a growth phase with appetite for channel-building investments, partnerships, and pilot programs to demonstrate product value in target markets.

Tech-enabled outreach Utilization of modern tech stack (AWS, WordPress, Shopify, marketing SEO tools) supports scalable online presence and e-commerce or partner portals; leverage for targeted digital campaigns to orthopedic surgeons, distributors, and medical device integrators.